Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Hormonothérapie
Extract
Randomized phase II study to investigate the efficacy, safety and tolerability of ZK 230211 (25 mg vs. 100 mg) as second-line endocrine therapy for postmenopausal women with hormone receptor-positive metastatic breast cancer.
Scientific Abstract
en cours d'intégration;